Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds

Journal of Biomedical Materials Research - Part A

Volumn 85, Issue 2, 2008, Pages 397-407

  Laschke, M W ^a   Rucker M ^a,b   Jensen, G ^a   Carvalho, C ^c   Mulhaupt R ^c   Gellrich, N C ^b   Menger, M D ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Biocompatibility; Matrigel; PLGA; Scaffold; Vascularization

Indexed keywords

BIOCOMPATIBILITY; ENDOTHELIAL CELLS; HISTOLOGY; IMMUNOLOGY; ORGANIC ACIDS; TISSUE ENGINEERING;

GROWTH FACTOR; GROWTH FACTOR REDUCED MATRIGEL (GFRM); IMMUNOHISTOCHEMISTRY; VASCULARIZATION;

BLOOD VESSELS;

GROWTH FACTOR; MATRIGEL; POLYGLACTIN; SCAFFOLD PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MOUSE; NONHUMAN; TISSUE ENGINEERING; VASCULAR RING; VASCULARIZATION;

ANIMALS; AORTA; CELL ADHESION; COLLAGEN; DRUG COMBINATIONS; IMPLANTS, EXPERIMENTAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTIC ACID; LAMININ; LEUKOCYTES; MATERIALS TESTING; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; PERICYTES; POLYGLYCOLIC ACID; POROSITY; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 42149131095     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31503     Document Type: Article

References (47)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
2. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 2005;4:518-524.
3. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 2003;65:489-497.
4. Helenius G, Backdahl H, Bodin A, Nannmark U, Gatenholm P, Risberg B. In vivo biocompatibility of bacterial cellulose. J Biomed Mater Res A 2006;76:431-438.
5. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med 1973;138:745-753.
6. Colton CK. Implantable biohybrid artificial organs. Cell Transplant 1995;4:415-436.
7. Mooney DJ, Kaufmann PM, Sano K, McNamara KM, Vacanti JP, Langer R. Transplantation of hepatocytes using porous, biodegradable sponges. Transplant Proc 1994;26:3425-3426.
8. Druecke D, Langer S, Lamme E, Pieper J, Ugarkovic M, Steinau HU, Homann HH. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: Long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A 2004;68:10-18.
9. Rücker M, Laschke MW, Junker D, Carvalho C, Schramm A, Mülhaupt R, Gellrich NC, Menger MD. Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice. Biomaterials 2006;27:5027-5038.
10. Laschke MW, Harder Y, Amon M, Martin I, Farhadi J, Ring A, Torio-Padron N, Schramm R, Rücker M, Junker D, Häufel JM, Carvalho C, Heberer M, Germann G, Vollmar B, Menger MD. Angiogenesis in tissue engineering: Breathing life into constructed tissue substitutes. Tissue Eng 2006;12:2093-2104.
11. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M. Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res 2001;58:449-455.
12. Ma Z, Gao C, Gong Y, Shen J. Cartilage tissue engineering PLLA scaffold with surface immobilized collagen and basic fibroblast growth factor. Biomaterials 2005;26:1253-1259.
13. Tabata Y, Miyao M, Yamamoto M, Ikada Y. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. J Biomater Sci Polym Ed 1999;10:957-968.
14. Folkman J, D'Amore PA. Blood vessel formation: What is its molecular basis? Cell 1996;87:1153-1155.
15. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.
16. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
17. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001;19:1029-1034.
18. Kleinman HK, Martin GR. Matrigel: Basement membrane matrix with biological activity. Semin Cancer Biol 2005;15:378-386.
19. Nicosia RF, Ottinetti A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 1990;26:119-128.
20. Lehr HA, Leunig M, Menger MD, Nolte D, Messmer K. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 1993;143:1055-1062.
21. Carvalho C, Landers R, Hübner U, Schmelzeisen R, Mülhaupt R. Fabrication of soft and hard biocompatible scaffolds using 3D-Bioplotting TM. In: Bártolo PJ, editor. Virtual Modelling and Rapid Manufacturing - Advanced Research in Virtual and Rapid Prototyping. London: Taylor & Francis; 2005. p 97-102.
22. Laschke MW, Häufel JM, Thorlacius H, Menger MD. New experimental approach to study host tissue response to surgical mesh materials in vivo. J Biomed Mater Res A 2005;74:696-704.
23. Menger MD, Pelikan S, Steiner D, Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: Significance of "reflow paradox". Am J Physiol 1992;263:H1901-H1906.
24. Baker M, Wayland H. On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res 1974;7:131-143.
25. Maxian SH, Di Stefano T, Melican MC, Tiku ML, Zawadsky JP. Bone cell behavior on Matrigel-coated Ca/P coatings of varying crystallinities. J Biomed Mater Res 1998;40:171-179.
26. Cronin KJ, Messina A, Knight KR, Cooper-White JJ, Stevens GW, Penington AJ, Morrison WA. New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plast Reconstr Surg 2004;113:260-269.
27. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
28. Beckert S, Farrahi F, Perveen Ghani Q, Aslam R, Scheuenstuhl H, Coerper S, Konigsrainer A, Hunt TK, Hussain MZ. IGF-I-induced VEGF expression in HUVEC involves phosphorylation and inhibition of poly(ADP-ribose)polymerase. Biochem Biophys Res Commun 2006;341:67-72.
29. van Cruijsen H, Giaccone G, Hoekman K. Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies. Int J Cancer 2005;117:883-888.
30. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685-693.
31. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001;19:1029-1034.
32. Koike N, Fukumura D, Gralla O, Au P, Schechner JS, Jain RK. Tissue engineering: Creation of long-lasting blood vessels. Nature 2004;428:138-139.
33. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998;125:1591-1598.
34. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: A critical overview. Clin Chem 2003;49:32-40.
35. Tremblay PL, Hudon V, Berthod F, Germain L, Auger FA. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 2005;5:1002-1010.
36. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
37. Laschke MW, Witt K, Pohlemann T, Menger MD. Injectable nanocrystalline hydroxyapatite paste for bone substitution: In vivo analysis of biocompatibility and vascularization. J Biomed Mater Res B Appl Biomater. (Epub ahead of print).
38. Menger MD, Walter P, Hammersen F, Messmer K. Quantitative analysis of neovascularization of different PTFE-implants. Eur J Cardiothorac Surg 1990;4:191-196.
39. Menger MD, Hammersen F, Messmer K. In vivo assessment of neovascularization and incorporation of prosthetic vascular biografts. Thorac Cardiovasc Surg 1992;40:19-25.
40. Klosterhalfen B, Hermanns B, Rosch R, Junge K. Biological response to mesh. Eur Surg 2003;35:16-20.
41. Möhle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997;94:663-668.
42. Shaw JP, Chuang N, Yee H, Shamamian P. Polymorphonuclear neutrophils promote rFGF-2-induced angiogenesis in vivo. J Surg Res 2003;109:37-42.
43. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27:3413-3431.
44. Nam YS, Yoon JJ, Park TG. A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. J Biomed Mater Res 2000;53:1-7.
45. Mikos AG, Bao Y, Cima LG, Ingber DE, Vacanti JP, Langer R. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res 1993;27:183-189.
46. Wake MC, Patrick CW Jr, Mikos AG. Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant 1994;3:339-343.
47. Deuel TF, Senior RM, Huang JS, Griffin GL. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 1982;69:1046-1049.